Interleukin‐6 is a significant predictor of radiographic knee osteoarthritis: The Chingford study

Abstract

Objective There is a great need for identification of biomarkers that could improve the prediction of early osteoarthritis (OA). We undertook this study to determine whether circulating levels of interleukin‐6 (IL‐6), tumor necrosis factor α (TNFα), and C‐reactive protein (CRP) can serve as useful markers of radiographic knee OA (RKOA) in a normal human population. Methods RKOA data were obtained from the cohort of the Chingford Study, a prospective population‐based study of healthy, middle‐aged British women. The RKOA‐affected status of the subjects was assessed using the Kellgren/Lawrence (K/L) grade as determined on radiographs obtained at baseline (n = 908) and at 10 years and 15 years thereafter. Serum levels of CRP, IL‐6, and TNFα were assayed at 5, 8, and 15 years, using high‐sensitivity commercial assays. A K/L grade of ≥2 in either knee was used as the outcome measure. Statistical analyses included analysis of variance for repeated measurements and logistic regression models, together with longitudinal modeling of dichotomous responses. Results During 15 years of followup, the prevalence of RKOA (K/L grade ≥2) increased from 14.7% to 48.7% ( P < 0.00001 versus baseline). The body mass index (BMI) and circulating levels of CRP and IL‐6 were consistently and significantly higher in subjects diagnosed as having RKOA. When multiple logistic regression was applied to the data, the variables of older age ( P = 3.93 × 10 −5 ), higher BMI at baseline ( P = 0.0003), and increased levels of IL‐6 at year 5 ( P = 0.0129) were determined to be independent predictors of the appearance of RKOA at year 10. The results were fully confirmed using longitudinal modeling of repeated measurements of the data obtained at 3 visits. The odds ratio for RKOA in subjects whose IL‐6 levels were in the fourth quartile of increasing levels (versus the first quartile) was 2.74 (95% confidence interval 1.94–3.87). Conclusion This followup study showed that individuals were more likely to be diagnosed as having RKOA if they had a higher BMI and increased circulating levels of IL‐6. These results should stimulate more work on IL‐6 as a potential therapeutic target.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 30

1. 1.

   The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 2003;919:i-x.

   Not in our library

2. 2.

   Reginster JY. The prevalence and burden of arthritis. Rheumatology (Oxford). 2002;41:3-6.

   Not in our library

3. 3.

   Katz JN. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol. 2006;30:145-53.

   Not in our library10.1016/j.berh.2005.09.003

4. 4.

   Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52:1105-13.

   Not in our library10.1111/j.1532-5415.2004.52308.x

5. 5.

   Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005;69:29-35.

   Not in our library10.1016/j.diabres.2004.11.007

6. 6.

   Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intense weight-loss therapy. J Am Geriatr Soc. 2008;56:644-51.

   Not in our library10.1111/j.1532-5415.2007.01636.x

7. 7.

   Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003;11:525-31.

   Not in our library10.1038/oby.2003.74

8. 8.

   Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev. 1988;9:57-66.

   Not in our library10.1210/edrv-9-1-57

9. 9.

   Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet. 1989;1:1122-6.

   Not in our library10.1016/s0140-6736(89)92394-5

10. 10.

    Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106-13.

    Not in our library10.1056/nejm199301143280207

11. 11.

    Fisher AL. Of worms and women: sarcopenia and its role in disability and mortality. J Am Geriatr Soc. 2004;52:1185-90.

    Not in our library10.1111/j.1532-5415.2004.52320.x

12. 12.

    Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 1996;97:244-9.

    Not in our library10.1172/jci118398

13. 13.

    Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15:49-60.

    Not in our library10.1016/j.cytogfr.2003.10.005

14. 14.

    Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 1989;143:3517-23.

    Not in our library

15. 15.

    Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242-8.

    Not in our library10.1093/gerona/59.3.m242

16. 16.

    Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40:723-7.

    Not in our library10.1002/art.1780400419

17. 17.

    Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213:626-34.

    Not in our library10.1002/jcp.21258

18. 18.

    Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage. 2007;15:516-23.

    Not in our library10.1016/j.joca.2006.10.010

19. 19.

    Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis: a population-based cohort study. Osteoarthritis Cartilage. 2008.

    Not in our library10.1016/j.joca.2008.07.003

20. 20.

    Dolan AL, Hart DJ, Doyle DV, Grahame R, Spector TD. The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford study. J Rheumatol. 2003;30:799-803.

    Not in our library

21. 21.

    Zhai G, Hart DJ, Valdes AM, Kato BS, Richards JB, Hakim A, et al. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int. 2008;19:1211-7.

    Not in our library10.1007/s00198-008-0562-x

22. 22.

    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.

    Not in our library10.1136/ard.16.4.494

23. 23.

    Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. 2008.

    Not in our library

24. 24.

    Felson DT. Clinical practice: osteoarthritis of the knee. N Engl J Med. 2006;354:841-8.

    Not in our library10.1056/nejmcp051726

25. 25.

    Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis: results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13:361-7.

    Not in our library10.1016/j.joca.2005.01.005

26. 26.

    Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis. 2008;67(Suppl 3):iii75-82.

    Not in our library10.1136/ard.2008.098764

27. 27.

    Sturmer T, Brenner H, Koenig W, Gunther KP. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis. 2004;63:200-5.

    Not in our library10.1136/ard.2003.007674

28. 28.

    Nathan C. Epidemic inflammation: pondering obesity. Mol Med. 2008;14:485-92.

    Not in our library10.2119/2008-00038.nathan

29. 29.

    Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953-6.

    Not in our library10.1016/s0899-9007(01)00672-4

30. 30.

    Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol. 1994;39:119-29.

    Not in our library10.1093/oxfordjournals.aje.a116974

Cited by papers we hold 4

• A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis · 2021
  Not checked
• Synovial Cytokines Significantly Correlate with Osteoarthritis-Related Knee Pain and Disability: Inflammatory Mediators of Potential Clinical Relevance · 2019
  No notice
• The association between body fat and musculoskeletal pain: a systematic review and meta-analysis · 2018
  No notice
• The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.